GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (BSP:N1VS34) » Definitions » Shiller PE Ratio

Novartis AG (BSP:N1VS34) Shiller PE Ratio : 17.88 (As of May. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Novartis AG Shiller PE Ratio?

As of today (2024-05-13), Novartis AG's current share price is R$50.42. Novartis AG's E10 for the quarter that ended in Mar. 2024 was R$2.82. Novartis AG's Shiller PE Ratio for today is 17.88.

The historical rank and industry rank for Novartis AG's Shiller PE Ratio or its related term are showing as below:

BSP:N1VS34' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.78   Med: 16.94   Max: 21.68
Current: 17.84

During the past years, Novartis AG's highest Shiller PE Ratio was 21.68. The lowest was 12.78. And the median was 16.94.

BSP:N1VS34's Shiller PE Ratio is ranked better than
68.61% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.645 vs BSP:N1VS34: 17.84

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2024 was R$6.524. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is R$2.82 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis AG Shiller PE Ratio Historical Data

The historical data trend for Novartis AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Shiller PE Ratio Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 19.66 16.02 16.45 16.42

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 17.37 18.16 16.42 16.89

Competitive Comparison of Novartis AG's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.



Novartis AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=50.42/2.82
=17.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.524/106.4611*106.4611
=6.524

Current CPI (Mar. 2024) = 106.4611.

Novartis AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 2.303 101.517 2.415
201409 3.063 101.247 3.221
201412 1.612 100.704 1.704
201503 16.712 100.339 17.732
201506 2.334 100.464 2.473
201509 3.005 99.785 3.206
201512 1.708 99.386 1.830
201603 3.106 99.475 3.324
201606 2.568 100.088 2.732
201609 2.635 99.604 2.816
201612 1.342 99.380 1.438
201703 2.189 100.040 2.330
201706 2.735 100.285 2.903
201709 2.757 100.254 2.928
201712 2.768 100.213 2.941
201803 2.820 100.836 2.977
201806 12.482 101.435 13.100
201809 2.835 101.246 2.981
201812 1.981 100.906 2.090
201903 2.919 101.571 3.060
201906 11.220 102.044 11.706
201909 3.666 101.396 3.849
201912 2.011 101.063 2.118
202003 4.642 101.048 4.891
202006 4.203 100.743 4.442
202009 4.536 100.585 4.801
202012 4.733 100.241 5.027
202103 5.128 100.800 5.416
202106 6.436 101.352 6.760
202109 6.440 101.533 6.753
202112 40.941 101.776 42.826
202203 4.927 103.205 5.082
202206 3.887 104.783 3.949
202209 3.775 104.835 3.834
202212 3.567 104.666 3.628
202303 5.625 106.245 5.636
202306 5.388 106.576 5.382
202309 4.198 106.570 4.194
202312 19.893 106.461 19.893
202403 6.524 106.461 6.524

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis AG  (BSP:N1VS34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (BSP:N1VS34) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (BSP:N1VS34) Headlines

No Headlines